Vivesto AB (Over The Counter Market:OASMY)
| 0.0003 Delayed Data As of May 22 |  0.00 / 0.00%Today’s Change | 0.00 Today|||52-Week Range 0.35 | -99.76% Year-to-Date |
Latest OASMY News | Press Releases
No recent news for Vivesto AB.
Today’s Trading
| Previous close | 0.00 |
| Today’s open | 0.00 |
| Day’s range | 0.00 - 0.00 |
| Volume | 200 |
| Average volume (3 months) | 5,771 |
| Market cap | $49.3K |
Data as of 05/22/2023
Growth & Valuation
| Earnings growth (last year) | +3.09% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -96.71% |
| P/E ratio | -- |
| Price/Sales | 204.89 |
| Price/Book | 0.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
| ---- | ||
| IDRSFIdorsia Ltd | 0.00 | 0.00% |
| BBIOBridgeBio Pharma Inc | +0.22 | +1.59% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Last reporting date | March 2, 2018 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $100.3K |
| Annual profit (last year) | -$16.5M |
| Net profit margin | -16,421.48% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Uppsala, Uppsala |
Forecasts
Chart unavailable
